Group 1 - Samsung Medical announced a business scope change for its wholly-owned subsidiary, Ningbo Samsung Intelligent Electric Co., Ltd. [2] - The necessary business registration changes have been completed, and a new business license has been issued by the Ningbo Market Supervision Administration. [2]

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-093 宁波三星医疗电气股份有限公司 关于全资子公司完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 因业务发展需要，宁波三星医疗电气股份有限公司（以下简称"公司"）全 资子公司宁波三星智能电气有限公司于近日进行了经营范围变更，相关工商变更 登记手续已办理完毕，并取得了宁波市市场监督管理局换发的《营业执照》。 工商登记变更后，相关登记信息如下： 法定代表人：程志浩 注册资本：64,165.28 万人民币 成立日期：2010 年 03 月 01 日 经营范围：一般项目：仪器仪表制造；仪器仪表销售；仪器仪表修理；电工 仪器仪表制造；电工仪器仪表销售；供应用仪器仪表制造；供应用仪器仪表销售； 充电桩销售；集中式快速充电站；新能源汽车电附件销售；电动汽车充电基础设 施运营；新能源汽车换电设施销售；通信设备制造；智能仪器仪表制造；智能仪 器仪表销售；电容器及其配套设备制造；电容器及其配套设备销售；智能家庭消 费设备制造；智能家庭消费设备销售；物联网 ...

Group 1 - Dongfang Electric announced that three executives plan to reduce their holdings by a total of no more than 30,000 shares due to personal financial needs [1] - Yahu Pharmaceutical's APL-1401 clinical trial data was presented at the 19th European Colorectal Congress, indicating progress in treating moderate to severe ulcerative colitis [1] - Guizhou Bai Ling's actual controller is under investigation by the China Securities Regulatory Commission for insider trading and information disclosure violations [3] Group 2 - Bairen Medical's ePTFE pericardial membrane product has been approved for registration, ending the reliance on imports for this product in the domestic market [4] - Qianxin received approval for a total of 2 billion yuan in technology innovation bonds, with plans to issue medium-term notes and short-term financing bonds [6] - Tengjing Technology's shareholder plans to reduce holdings by no more than 1.96% of the company's shares [7] Group 3 - Yuntianhua's subsidiary is required to pay 386 million yuan in overdue taxes and penalties, which will impact the company's net profit for 2025 [8] - Jianyou Pharmaceutical's propofol emulsion injection has received FDA approval in the United States [9] - Suzhou Gaoxin successfully acquired land use rights for a residential project for 360 million yuan [9] Group 4 - Chalco International's subsidiary won a bid for a 3.03 billion yuan electrolytic aluminum project [11] - Tai Long Pharmaceutical's stock will continue to be suspended due to potential changes in control as the major shareholder is planning a share transfer [12] - Qianli Technology reported a 63.44% year-on-year increase in automobile sales for November, although new energy vehicle sales decreased by 43.98% [13] Group 5 - Fosun Pharma's innovative drug FXS0887 has received approval for a Phase I clinical trial for advanced malignant solid tumors [14] - Guoen Co. has obtained approval for a project to produce 20,000 square meters of aviation-grade acrylic glass, with a total investment of 560 million yuan [15] - Guofa Co.'s chairman resigned due to personal reasons [17] Group 6 - Shanghai Construction won a bid for a state-owned construction land use right for 264 million yuan [18] - Weixin Kang's subsidiary received approval for a clinical trial of lidocaine cream for local anesthesia [20] - Sanxing Medical's subsidiary is a candidate for a 152 million yuan transformer procurement project for the State Grid [20] Group 7 - People's Daily announced the resignation of its president due to work changes, while retaining other leadership roles [21] - Beibu Gulf Port reported a 0.29% year-on-year increase in cargo throughput for November [22] - Chongqing Construction won three engineering projects with a total value of approximately 2.773 billion yuan [23] Group 8 - Xingyu Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [24] - Huajian Group signed a design contract worth 160 million yuan for a comprehensive project [25] - Wankai New Materials plans to invest 350 million yuan in a technical transformation project for producing 100,000 tons of adipic acid [26] Group 9 - Kaipuyun received a government subsidy of 18 million yuan, which is 87.43% of its net profit for the last audited fiscal year [28] - Ningbo Port expects a 10.8% year-on-year increase in container throughput for November [30] - An Cai High-Tech plans to invest 498 million yuan to upgrade its photovoltaic glass production line [32] Group 10 - Shunhao Co. stated that its existing business has not generated synergies with the rail business, which faces various risks [34] - Yihualu plans to publicly transfer 35% of its stake in Liaoyun Company [35] - ST Wanfang's shareholder plans to reduce holdings by no more than 3% of the company's shares [36] Group 11 - Youyou Food's shareholder plans to reduce holdings by no more than 110,000 shares [38] - Hengtong Optic-Electric's incentive fund has spent 49.98 million yuan to purchase company shares [41] - Zoli Pharmaceutical plans to issue convertible bonds to raise no more than 1.556 billion yuan for various projects [42]

Group 1 - The high-pressure oxygen chamber concept increased by 0.92%, ranking second among concept sectors, with eight stocks rising, including Hangzhou Oxygen, Dahu Co., and Jinling Pharmaceutical, which rose by 5.56%, 1.13%, and 1.09% respectively [1] - The leading stocks in terms of net inflow of main funds in the high-pressure oxygen chamber sector include Samsung Medical, with a net inflow of 4.9759 million yuan, followed by Aoyang Health, Yingkang Life, and Weiao Co. [2][3] - The net inflow ratios for Yingkang Life, Weiao Co., and Aoyang Health were 2.53%, 1.60%, and 1.49% respectively, indicating strong interest from main funds [3] Group 2 - The high-pressure oxygen chamber sector experienced a net outflow of 45 million yuan today, despite some stocks seeing net inflows [2] - Stocks with significant declines include Beiyikang, China Railway Construction, and Yingkang Life, which fell by 0.40%, 0.20%, and 0.20% respectively [1] - The trading volume and turnover rates for stocks like Hangzhou Oxygen and International Medical showed negative net inflows, indicating potential selling pressure [4]

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-092 宁波三星医疗电气股份有限公司 关于经营合同预中标的提示性公告 本公司董事会及全体董事保证公告内容不存在虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波三星医疗电气股份有限公司（以下简称"公司"）下属全资子公司宁波奥克斯 智能科技股份有限公司（以下简称"奥克斯智能科技"）于近日在国家电网有限公司 2025 年华中、川渝区域第二次联合采购 10kV 柱上变压器台成套设备协议库存招标采 购，国家电网有限公司 2025 年华中、川渝区域第二次联合采购 10kV 变压器协议库存 招标采购项目中被推荐为中标候选人，预计合计中标总金额约为 15,179.71 万元，现 将预中标情况公告如下： 一、国家电网项目预中标的主要内容 1、国家电网有限公司2025年华中、川渝区域第二次联合采购10kV柱上变压器台 成套设备协议库存招标采购项目 国家电网有限公司于近日在其电子商务平台（http://ecp.sgcc.com.cn）公告"国家 电网有限公司2025年华中、川渝区域第二次联合采购10kV柱上变压器台成套设备 ...

Group 1 - The core point of the article is that Samsung Medical's subsidiary, Ningbo Aux Intelligent Technology Co., Ltd., has been recommended as a candidate for winning a bid in the State Grid Corporation of China's procurement project for 10kV transformers, with an expected total bid amount of approximately 152 million yuan [1] Group 2 - The procurement project is part of the State Grid Corporation's 2025 joint procurement for the Central China and Sichuan-Chongqing regions [1] - The specific equipment involved in the procurement is 10kV pole-mounted transformer complete sets [1] - The announcement indicates a significant opportunity for the company in the energy sector, particularly in the context of infrastructure development [1]

Core Viewpoint - Samsung Medical (601567.SH) announced that its wholly-owned subsidiary, Ningbo Aux Intelligent Technology Co., Ltd. (referred to as "Aux Intelligent Technology"), has been recommended as a candidate for winning a bid in the State Grid Corporation of China's 2025 joint procurement for 10kV pole-mounted transformer equipment in the Central China and Sichuan-Chongqing regions, with an estimated total bid amount of approximately 152 million yuan [1] Group 1 - The company’s subsidiary, Aux Intelligent Technology, participated in a significant procurement project by the State Grid Corporation of China [1] - The total estimated bid amount for the project is around 152 million yuan [1] - The procurement is part of the 2025 joint procurement initiative for the Central China and Sichuan-Chongqing regions [1]

Group 1 - The core announcement is that Samsung Medical's wholly-owned subsidiary, Ningbo Aokex Intelligent Technology Co., Ltd., has been recommended as a candidate for winning bids in the National Grid Corporation's procurement projects for 10kV pole-mounted transformers and related equipment [1] - The total expected bid amount for these projects is approximately 152 million yuan [1]

Group 1 - The core point of the article is that Samsung Medical (601567.SH) announced that its wholly-owned subsidiary, Aix Intelligent Technology, has been recommended as a candidate for winning a bid in the State Grid Corporation's procurement for 10kV pole-mounted transformers in the Central China and Sichuan-Chongqing regions for 2025, with an expected total bid amount of approximately 152 million yuan [1] Group 2 - The procurement project involves the second joint procurement of 10kV transformers by the State Grid Corporation for the year 2025 [1] - The total expected bid amount of 152 million yuan indicates a significant opportunity for the company in the energy equipment sector [1]

Core Viewpoint - Samsung Medical (601567) announced that its wholly-owned subsidiary, Ningbo Aokeshi Intelligent Technology Co., Ltd., has been recommended as a candidate for winning a bid in the State Grid Corporation of China's 2025 joint procurement for 10kV pole-mounted transformers in the Central China and Sichuan-Chongqing regions, with an expected total bid amount of approximately 152 million yuan [1] Group 1 - The company’s subsidiary has participated in a significant procurement project by the State Grid Corporation of China [1] - The total expected bid amount for the project is around 152 million yuan [1] - The procurement is part of the 2025 joint procurement initiative for the Central China and Sichuan-Chongqing regions [1]